Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice

Cyriac Peters-Veluthamaningal, Jan C Winters, Klaas H Groenier, Betty Meyboom-de Jong, Cyriac Peters-Veluthamaningal, Jan C Winters, Klaas H Groenier, Betty Meyboom-de Jong

Abstract

Background: Carpal tunnel syndrome is caused by entrapment of the median nerve and results in pain, tingling and numbness in the wrist and hand. It is a common condition in general practice. Effectiveness of treatment by intracarpal corticosteroid injection has never been investigated in general practice. The objective of this study was to determine if corticosteroid injections for carpal tunnel syndrome provided by general practitioners are effective.

Methods: In this study 69 participants with a clinical diagnosis of carpal tunnel syndrome were recruited from 20 general practices. Short-term outcomes were assessed in a randomised, placebo-controlled trial. Long-term results were assessed in a prospective cohort-study of steroid responders. Participants were randomised to intracarpal injections of 1 ml triamcinolonacetonide 10 mg/ml (TCA) or 1 ml NaCl (placebo). Non-responders to NaCl were treated with additional TCA injections. Main outcomes were immediate treatment success, mean score of the Symptom Severity Scale (SSS) and Functional Status Scale (FSS) of the Boston carpal tunnel questionnaire, subjective improvement and proportion of participants with recurrences during follow-up. Duration of follow-up was twelve months.

Results: The TCA-group (36 participants) had better outcomes than the NaCl-group (33 participants) during short-term assessment for outcome measures treatment response, mean improvement of SSS-score (the mean difference in change score was 0.637 {95% CI: 0.320, 0.960; p < 0.001}) and FSS-score (the mean difference in change score was 0.588 {95% CI: 0.232, 0.944; p = 0.002}) and perceived improvement (p = 0.01). The number to treat to achieve satisfactory partial treatment response or complete resolution of symptoms and signs was 3 (95% CI:1.83, 9.72).49% of TCA-responders (17/35) had recurrences during follow-up. In the group of TCA-responders without recurrences (51%, 18/35) outcomes for SSS-score and FSS-score deteriorated during the follow-up period of 12 months (resp. p = 0.008 and p = 0.012).

Conclusions: Corticosteroid injections for CTS provided by general practitioners are effective regarding short-term outcomes when compared to placebo injections. The short-term beneficial treatment effects of steroid injections deteriorated during the follow-up period of twelve months and half of the cohort of steroid-responders had recurrences.

Trial registration: Current Controlled Trials ISRCTN53171398.

Figures

Figure 1
Figure 1
flow of patients during intervention phase
Figure 2
Figure 2
BCTQ symptom score of responders to TCA during follow-up
Figure 3
Figure 3
BCTQ functional score of responders to TCA during follow-up

References

    1. Katz JN, Simmons BP. Clinical practice. Carpal tunnel syndrome. N Engl J Med. 2002;346:1807–1812. doi: 10.1056/NEJMcp013018.
    1. de Krom MC, van Croonenborg JJ, Blaauw G, Scholten RJ, Spaans F. [Guideline 'Diagnosis and treatment of carpal tunnel syndrome'] Ned Tijdschr Geneeskd. 2008;152:76–81.
    1. Bland JD. Carpal tunnel syndrome. Bmj. 2007;335:343–346. doi: 10.1136/.
    1. de Krom MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F. Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol. 1992;45:373–376. doi: 10.1016/0895-4356(92)90038-O.
    1. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk. Huisartsenzorg: wat doet de poortwachter?
    1. Bongers FJ, Schellevis FG, van den Bosch WJ, van der Zee J. Carpal tunnel syndrome in general practice (1987 and 2001): incidence and the role of occupational and non-occupational factors. Br J Gen Pract. 2007;57:36–39.
    1. Anonymous. Practice parameter for carpal tunnel syndrome (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1993;43:2406–2409.
    1. Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007. p. CD001554.
    1. Bland JD. Treatment of carpal tunnel syndrome. Muscle Nerve. 2007;36:167–171. doi: 10.1002/mus.20802.
    1. O'Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev. 2003. p. CD003219.
    1. Verdugo RJ, Salinas RA, Castillo JL, Cea JG. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database Syst Rev. 2008. p. CD001552.
    1. D'Arcy CA, McGee S. The rational clinical examination. Does this patient have carpal tunnel syndrome? Jama. 2000;283:3110–3117. doi: 10.1001/jama.283.23.3110.
    1. Leite JC, Jerosch-Herold C, Song F. A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskelet Disord. 2006;7:78. doi: 10.1186/1471-2474-7-78.
    1. Dammers JW, Veering MM, Vermeulen M. Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. Bmj. 1999;319:884–886.
    1. Armstrong T, Devor W, Borschel L, Contreras R. Intracarpal steroid injection is safe and effective for short-term management of carpal tunnel syndrome. Muscle Nerve. 2004;29:82–88. doi: 10.1002/mus.10512.
    1. Schafer. Analysis of Incomplete Multivariate Data. Chapman and Hall, London; 1997. pp. 37–89.
    1. Schrijver HM, Gerritsen AA, Strijers RL, Uitdehaag BM, Scholten RJ, de Vet HC, Bouter LM. Correlating nerve conduction studies and clinical outcome measures on carpal tunnel syndrome: lessons from a randomized controlled trial. J Clin Neurophysiol. 2005;22:216–221.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe